We observed that the administration of oxaliplatin reduced the tumour volume when HT29-P cells were carrying an empty vector or expressing F-CHK2-DA, whereas the size of tumours raised from the cells expressing F-CHK2-WT or F-CHK2-TD was sustained (Fig. 5f and Supplementary Fig. 4d). This evidence concerns the gene CHEK2 and neoplasm.